Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)
Condition: Metastatic Prostate Cancer Interventions: Drug: Enzalutamide; Drug: Talazoparib Sponsors: MedSIR; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials